Antipsychotic use and psychiatric disorders in COVID-19
- PMID: 33665642
- PMCID: PMC7906667
- DOI: 10.1016/S2666-7568(20)30063-5
Antipsychotic use and psychiatric disorders in COVID-19
Comment in
-
Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? - Authors' reply.Lancet Healthy Longev. 2021 Feb;2(2):e65. doi: 10.1016/S2666-7568(21)00007-6. Epub 2021 Feb 3. Lancet Healthy Longev. 2021. PMID: 33665643 Free PMC article. No abstract available.
Comment on
-
Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis.Lancet Healthy Longev. 2020 Nov;1(2):e69-e79. doi: 10.1016/S2666-7568(20)30013-1. Epub 2020 Oct 26. Lancet Healthy Longev. 2020. PMID: 33521769 Free PMC article.
References
-
- Dzahini O, Singh N, Taylor D, Haddad PM. Antipsychotic drug use and pneumonia: systematic review and meta-analysis. J Psychoparmacol. 2018;32:1167–1181. - PubMed
-
- van Strien AM, Souverein PC, Keijsers CJPW, Heerdink ER, Derijks HJ, van Marum RJ. Association between urinary tract infections and antipsychotic drug use in older adults. J Clin Psychoparmacol. 2018;24:296–301. - PubMed
-
- Augusto F, Belen B, Tentoni N, et al. Antipsychotic use and bloodstream infections among patients with chronic obstructive pulmonary disease: a cohort study. J Clin Psychiatry (in press). - PubMed
-
- Govind R, Fonseca de Freitas D, Pritchard M, Hayes RD, MacCabe JH. Clozapine treatment and risk of COVID-19 infection: retrospective cohort study. Br J Psychiatry. 2020 https://doi:10.1192/bjp.2020.151 published online July 27. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
